S&P 500
7,704.57
+37.97
+0.50%
Dow
53,357.34
+295.39
+0.56%
Nasdaq
26,448.82
+230.99
+0.88%
NYSE Composite
24,559.27
+63.72
+0.26%
Russell 2000
2,955.67
+2.51
+0.08%
VIX
15.06
-0.14
-0.92%
KEQU · Kewaunee Scientific Corporation
NASDAQ NMS - GLOBAL MARKET - Real Time Price • USD
Kewaunee Scientific Corp (KEQU)
NASDAQ NMS - GLOBAL MARKET
Health Care
$35.90
-0.87
(-2.37%)
● Market open
DAY'S RANGE
$35.90
$35.90
$35.90
52-WEEK RANGE
$35.90
$33.27
$58.95
What's happening
- KEQU is down 2.37% today, trading at $35.90. — Live quote
- Volume today (102) is well below its 3-month average of 3,960. (Finnhub fundamentals)
- Reports earnings on 2026-09-09 (after market close), 6 days away. (Finnhub earnings calendar)
Deterministic template sentences filled in from the same sourced figures shown elsewhere on this page -- not an AI-written summary, no live model call.
Key Statistics
Analyst Recommendations
Strong buy 2
Buy 4
Hold 1
Sell 0
Strong sell 0
Aggregate ratings for 2021-12-01 (7 analysts polled by Finnhub) — consensus count.
Performance Overview (Trailing returns vs S&P 500 benchmark)
YTD RETURN
KEQU
+0.69%
vs S&P 500
-9.42%
1-YEAR RETURN
KEQU
+6.35%
vs S&P 500
-6.06%
6-MONTH RETURN
KEQU
-7.24%
3-MONTH RETURN
KEQU
-7.56%
Earnings Trends (Quarterly EPS Actual vs Estimate)
2027-01-26 (Q4 2026)
$1.14
Est. $—
2026-10-26 (Q3 2026)
$0.28
Est. $—
2026-07-26 (Q2 2026)
$0.91
Est. $—
2026-04-26 (Q1 2026)
$1.10
Est. $—
Valuation Measures & Ratios
Enterprise Value4$141.5M
Forward P/E5—
PEG Ratio6—
Price / Sales (TTM1)0.37
Price / Book71.42
EV4 / Revenue0.50
EV4 / EBITDA6.15
Profit Margin3.41%
Operating Margin5.93%
Return on Equity (ROE8)13.63%
Return on Assets (ROA9)5.22%
Avg Volume (3M)3,960
Quarterly history (5 periods)
| Measure | Jan '26 | Oct '25 | Jul '25 | Jan '25 | Oct '24 |
|---|---|---|---|---|---|
| Market cap | $121.0M | $134.9M | $165.1M | $193.0M | $96.0M |
| P/E | 15.96 | 13.63 | 17.11 | 21.27 | 9.18 |
| Price/Sales | 0.44 | 0.53 | 0.70 | 0.92 | 0.50 |
| Price/Book | 1.71 | 1.93 | 2.46 | 3.17 | 1.62 |
| EV/Revenue | 0.47 | 0.60 | 0.77 | 1.04 | 0.36 |
| EV/EBITDA | 6.45 | 7.32 | 9.57 | — | — |
| ROE | 10.73% | 14.17% | 14.38% | 14.93% | 17.62% |
| ROA | 4.31% | 5.24% | 4.99% | 4.80% | 7.77% |
Trailing-twelve-month ratios computed from SEC EDGAR quarterly figures and historical daily close prices (Alpaca). Diluted shares are derived from Net income ÷ EPS (diluted) for each quarter, not separately reported. Forward P/E and PEG aren't shown here — both need historical analyst-consensus estimates, which no free source provides; see the current-period figures above instead.
Glossary — what these abbreviations mean
- 1. TTM
- Trailing twelve months — the sum of the last four reported quarters, not a calendar year or the single latest quarter.
- 2. EPS
- Earnings per share — net income divided by diluted shares outstanding.
- 3. Beta
- A stock's historical volatility relative to the overall market. Above 1 means it has moved more than the market; below 1, less.
- 4. EV (Enterprise Value)
- Market cap plus total debt minus cash — roughly what it would cost to buy the whole company, debt included.
- 5. Forward P/E
- Price divided by analysts' estimated earnings for the next 12 months, instead of trailing actual earnings.
- 6. PEG Ratio
- P/E divided by expected earnings growth rate. A lower number can indicate a stock is cheap relative to how fast it's expected to grow.
- 7. Price / Book
- Share price divided by book value (assets minus liabilities) per share.
- 8. ROE
- Return on equity — net income divided by shareholders' equity, a measure of how efficiently a company turns equity into profit.
- 9. ROA
- Return on assets — net income divided by total assets, a measure of how efficiently a company turns assets into profit.
- 10. MRQ
- Most recent quarter — the single latest reported period, as opposed to TTM. The Financials section's "Quarterly" view below shows MRQ-style figures.
- 11. YoY
- Year over year — percent change versus the same period one year earlier, used for growth figures like those on Compare cards and the Screener.
Short Interest
Shares Short44,564
Change from Prior Settlement-6.33%
% of Float—
Days to Cover (Short Ratio)12.70
Source: FINRA Rule 4560 consolidated short interest, settlement date 2026-08-14. Reported bi-monthly with a reporting lag — not real-time.
Quotes and the 1-day extended-hours chart: Yahoo Finance. Longer historical charts: Alpaca (IEX feed) — real-time but IEX-only volume (~2.5% of consolidated market volume). Fundamentals + earnings: Finnhub.
Price history
Events
Drag horizontally to zoom into a section; use Reset view to restore all observations.
Technical signal summary
Calculating from the latest year of daily price history…
Show Technical Analysis Breakdown ▾ 10 Indicators
Signals describe daily price patterns—not the company’s value and not a recommendation to buy or sell. Read several together; no single indicator predicts what happens next. “Overbought” and “oversold” are conditions, not promises of a reversal.
Indicators None active
Loading chart…
Free IEX historical data only goes back to ~2021 — 5Y/Full show whatever's actually available, not a promise of that much history. Indicators are computed client-side from these same price bars; earnings markers ("E") come from Finnhub's free tier (~last 4 quarters + next upcoming) — older quarters aren't available. The move-highlight dots are a heuristic (|% change| vs rolling volatility) with a best-effort headline lookup, not a claim of causation.
Peer and sector context
No reviewed peer group is available for this symbol.
Balanced evidence
A deterministic summary of sourced facts—not an AI verdict.
Potential strengths
- Trailing 52-week price return is +6.3%. Finnhub market metrics ↗
- Latest SEC filing is Form 8-K, filed 2026-08-27; review it for current changes and risks. SEC EDGAR ↗
Potential concerns
- Revenue growth is -7.5% on the provider's reported measure. Finnhub fundamentals ↗
- Net profit margin is 3.4%. Finnhub fundamentals ↗
Rule-based facts only; absence from either side is not evidence, and this is not a recommendation.
More on KEQU
No accessible free API for these — links go to the source directly.
Financials
Fundamental trends
Visualized from the same SEC figures in the tables below.
Income statement
| Line item | Jan '26 | Oct '25 | Jul '25 | Jan '25 | Oct '24 | Jul '24 | Jan '24 | Oct '23 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $69.4M | $70.1M | $71.1M | $67.2M | $47.8M | $48.4M | $46.8M | $50.4M |
| Gross profit | $18.5M | $19.7M | $20.9M | $18.4M | $14.0M | $12.5M | $12.0M | $13.5M |
| Operating income | $2.6M | $4.1M | $4.8M | $2.2M | $4.4M | $2.6M | $3.8M | $5.1M |
| Net income | $692.0K | $2.4M | $3.1M | $1.4M | $3.0M | $2.2M | $2.5M | $2.7M |
| EPS (diluted) | $0.23 | $0.82 | $1.04 | $0.45 | $1.01 | $0.74 | $0.85 | $0.93 |
| EPS (basic) | $0.24 | $0.85 | $1.08 | $0.47 | $1.05 | $0.77 | $0.87 | $0.94 |
| Operating margin | $4 | $6 | $7 | $3 | $9 | $5 | $8 | $10 |
| Net margin | $1 | $3 | $4 | $2 | $6 | $5 | $5 | $5 |
Balance sheet
| Line item | Apr '26 | Jan '26 | Oct '25 | Jul '25 | Apr '25 | Jan '25 | Oct '24 | Jul '24 |
|---|---|---|---|---|---|---|---|---|
| Total assets | $178.3M | $176.0M | $189.1M | $193.5M | $194.7M | $189.1M | $134.5M | $132.0M |
| Total liabilities | $101.5M | $103.4M | $117.4M | $124.6M | $128.4M | $127.0M | $73.8M | $74.5M |
| Stockholders' equity | $74.7M | $70.7M | $69.9M | $67.1M | $64.5M | $60.8M | $59.3M | $56.0M |
| Total current assets | $105.4M | $103.6M | $113.6M | $117.1M | $118.4M | $108.6M | $96.4M | $92.7M |
| Total current liabilities | $48.4M | $48.8M | $45.8M | $50.5M | $53.7M | $50.2M | $36.5M | $36.7M |
| Cash & equivalents | $9.9M | $8.2M | $12.6M | $19.5M | $14.9M | $9.5M | $26.0M | $24.2M |
| Accounts receivable | $58.7M | $54.1M | $59.0M | $56.9M | $62.4M | $57.4M | $41.9M | $43.5M |
| Inventory | $30.5M | $32.9M | $35.5M | $34.9M | $32.8M | $31.6M | $18.7M | $19.3M |
| Property, plant & equipment | $22.4M | $22.6M | $23.2M | $22.8M | $23.2M | $23.8M | $17.0M | $17.1M |
| Goodwill | $12.5M | $12.5M | $12.5M | $12.5M | $12.5M | $14.2M | — | — |
| Intangible assets | $16.3M | $16.7M | $17.1M | $17.4M | $17.8M | $18.2M | — | — |
| Other non-current assets | $7.1M | $6.6M | $7.4M | $7.4M | $5.8M | $6.5M | $5.8M | $7.2M |
| Accounts payable | $22.5M | $23.6M | $22.7M | $26.3M | $27.0M | $24.5M | $21.5M | $20.6M |
| Accrued liabilities | — | — | — | — | — | — | — | — |
| Deferred revenue (current) | $4.2M | $4.1M | $4.3M | $5.0M | $6.1M | $7.8M | $6.2M | $4.9M |
| Short-term debt | $74.0K | — | — | — | $986.0K | — | — | — |
| Other current liabilities | — | — | — | — | — | — | — | — |
| Long-term debt | $15.1M | $16.3M | $32.2M | $34.4M | $34.7M | $35.0M | — | — |
| Other non-current liabilities | $290.0K | $337.0K | $349.0K | $353.0K | $364.0K | $447.0K | $460.0K | $462.0K |
| Common stock & paid-in capital | $7.4M | $7.4M | $7.4M | $7.4M | $7.4M | $7.4M | $7.4M | $7.4M |
| Retained earnings | $68.5M | $65.1M | $64.5M | $62.0M | $58.9M | $54.1M | $52.7M | $49.7M |
| Accumulated other comprehensive income (loss) | -$4.6M | -$4.8M | -$4.4M | -$4.2M | -$3.8M | -$3.8M | -$3.6M | -$3.5M |
Cash flow
| Line item | Apr '26 | Jan '26 | Oct '25 | Jul '25 | Apr '25 | Jan '25 | Oct '24 | Jul '24 |
|---|---|---|---|---|---|---|---|---|
| Operating cash flow | $5.5M | $11.6M | -$4.3M | $5.8M | $9.4M | -$2.3M | $8.4M | -$794.0K |
| Investing cash flow | -$928.0K | -$668.0K | -$1.6M | -$771.0K | -$516.0K | -$29.4M | -$683.0K | -$278.0K |
| Financing cash flow | -$3.0M | -$14.1M | -$853.0K | -$1.5M | -$4.3M | $14.6M | -$3.2M | $343.0K |
| Depreciation & amortization | $4.7M | $1.6M | $1.6M | $1.5M | $3.9M | $1.6M | $806.0K | $815.0K |
| Share-based compensation | $502.0K | $542.0K | $561.0K | $521.0K | $370.0K | $380.0K | $373.0K | $318.0K |
| Deferred income taxes | -$20.0K | — | — | — | -$2.2M | — | — | — |
| Change in accounts receivable | $4.9M | -$4.8M | $2.1M | -$5.5M | $4.9M | $5.0M | -$1.6M | -$1.5M |
| Change in inventory | -$2.4M | -$2.6M | $576.0K | $2.1M | -$489.0K | -$843.0K | -$626.0K | -$1.4M |
| Dividends paid | — | — | — | — | — | — | — | — |
| Share repurchases | $0 | — | — | — | $1.6M | $0 | — | — |
| Debt issued | — | — | — | — | — | — | — | — |
| Debt repaid | — | — | — | — | — | — | — | — |
Income statement
| Line item | Apr '26 | Apr '25 | Apr '24 | Apr '23 | Apr '22 |
|---|---|---|---|---|---|
| Revenue | $282.0M | $240.5M | $203.8M | $219.5M | $168.9M |
| Gross profit | $80.4M | $68.9M | $52.1M | $35.6M | $24.2M |
| Operating income | $16.7M | $17.8M | $18.3M | $5.4M | -$2.6M |
| Net income | $9.6M | $11.4M | $18.8M | $738.0K | -$6.1M |
| EPS (diluted) | $3.22 | $3.83 | $6.38 | $0.25 | $-2.20 |
| EPS (basic) | $3.36 | $3.98 | $6.51 | $0.26 | $-2.20 |
| Operating margin | $6 | $7 | $9 | $2 | -$2 |
| Net margin | $3 | $5 | $9 | $0 | -$4 |
Balance sheet
| Line item | Apr '26 | Apr '25 | Apr '24 | Apr '23 | Apr '22 |
|---|---|---|---|---|---|
| Total assets | $178.3M | $194.7M | $134.8M | $118.9M | $118.8M |
| Total liabilities | $101.5M | $128.4M | $78.6M | $80.4M | $82.6M |
| Stockholders' equity | $74.7M | $64.5M | $54.8M | $37.4M | $35.7M |
| Total current assets | $105.4M | $118.4M | $96.8M | $87.9M | $91.6M |
| Total current liabilities | $48.4M | $53.7M | $40.8M | $40.1M | $42.3M |
| Cash & equivalents | $9.9M | $14.9M | $23.3M | $8.1M | $4.4M |
| Accounts receivable | $58.7M | $62.4M | $45.1M | $46.1M | $41.3M |
| Inventory | $30.5M | $32.8M | $20.7M | $21.9M | $23.8M |
| Property, plant & equipment | $22.4M | $23.2M | $17.6M | $16.4M | $15.1M |
| Goodwill | $12.5M | $12.5M | $0 | — | — |
| Intangible assets | $16.3M | $17.8M | $0 | — | — |
| Other non-current assets | $7.1M | $5.8M | $5.4M | $5.4M | $4.5M |
| Accounts payable | $22.5M | $27.0M | $23.3M | $23.6M | $27.3M |
| Accrued liabilities | — | — | — | — | — |
| Deferred revenue (current) | $4.2M | $6.1M | $4.4M | $4.1M | $3.5M |
| Short-term debt | $74.0K | $986.0K | $3.1M | $3.6M | $1.6M |
| Long-term debt | $15.1M | $34.7M | — | — | — |
| Other non-current liabilities | $290.0K | $364.0K | $462.0K | $455.0K | $531.0K |
| Common stock & paid-in capital | $7.4M | $7.4M | $7.3M | $7.1M | $7.0M |
| Retained earnings | $68.5M | $58.9M | $47.5M | $28.8M | $28.0M |
| Accumulated other comprehensive income (loss) | -$4.6M | -$3.8M | -$3.4M | -$3.4M | -$3.7M |
Cash flow
| Line item | Apr '26 | Apr '25 | Apr '24 | Apr '23 | Apr '22 |
|---|---|---|---|---|---|
| Operating cash flow | $18.6M | $14.8M | $19.6M | -$3.8M | -$7.9M |
| Investing cash flow | -$3.9M | -$30.9M | -$4.4M | -$4.1M | -$1.9M |
| Financing cash flow | -$19.3M | $7.4M | -$3.0M | $14.9M | $11.0M |
| Depreciation & amortization | $6.3M | $4.8M | $3.1M | — | — |
| Share-based compensation | $2.1M | $1.4M | $1.0M | $886.0K | $729.0K |
| Deferred income taxes | -$20.0K | -$2.2M | -$11.0M | $515.0K | $121.0K |
| Change in accounts receivable | -$3.3M | $6.7M | -$741.0K | $4.9M | $8.5M |
| Change in inventory | -$2.3M | -$3.4M | -$1.2M | -$1.9M | $7.3M |
| Dividends paid | — | — | — | — | — |
| Share repurchases | $0 | $1.6M | $2.0M | $0 | — |
| Debt issued | — | — | $202.0K | $0 | $377.0K |
| Debt repaid | — | — | $88.0K | $121.0K | $0 |
Source: SEC EDGAR XBRL filings (10-Q/10-K), as originally tagged by the company. Quarterly cash flow is reconstructed by de-cumulating fiscal-year-to-date figures (how cash flow is tagged in 10-Qs); other quarterly lines are reported directly.
Institutional holders
SEC Form 13F filers holding KEQU as of the latest reported quarter. 13F only covers investment managers with $100M+ in assets — this is not a complete ownership picture, and does not include insiders (see Recent SEC filings below) or non-13F-eligible holders.
Institutional ownership is not available for this symbol right now.
Insider activity
Directors, officers, and 10%+ owners' reported transactions from SEC Form 4. A filing reports a transaction; it does not by itself explain why it happened.
Source: SEC EDGAR Form 4 filings · checked 25 most recent filings · covers 2025-09-29 to 2026-06-30
Recent transactions
- Most recent: Phillips Elizabeth D (SVP, People & Culture) — Option exercise of 6,656 shares on 2026-06-30.
Deterministic template sentences filled in from the SEC Form 4 figures in the tables below -- not an AI-written summary, no live model call.
Insider purchases & sales, last 6 months
Purchases (open market)0 sh(0 txns)
Sales (open market)0 sh(0 txns)
Net Shares+0
Counts only open-market purchases (code P) and sales (code S) — grants, option exercises, tax withholding, and gifts are excluded since they aren't a market buy/sell decision.
Insider roster
| Name | Title | Most Recent Transaction | Date | Shares |
|---|---|---|---|---|
| Phillips Elizabeth D | SVP, People & Culture | Option exercise | 2026-06-30 | 6,656 |
| Ranade Mandar | SVP, IT & Engineering | Option exercise | 2026-06-30 | 7,227 |
| Noble Ryan S. | SVP, Sales & Marketing Dev | Option exercise | 2026-06-30 | 7,206 |
| Batdorff Douglas J. | SVP, Manufacturing Operations | Option exercise | 2026-06-30 | 7,451 |
| Gardner Donald T. III | Chief Financial Officer | Option exercise | 2026-06-30 | 21,265 |
| HULL THOMAS DAVID III | President & CEO | Option exercise | 2026-06-30 | 54,388 |
| Campbell John Jette | Director | Grant / award | 2026-05-01 | 2,013 |
| GEHL KEITH M | Director | Grant / award | 2026-05-01 | 2,013 |
| PYLE MARGARET B | Director | Gift | 2026-03-26 | 2,750 |
Recent transactions
| Date | Insider | Title | Transaction | Shares | Price |
|---|---|---|---|---|---|
| 2026-06-30 | Phillips Elizabeth D | SVP, People & Culture | Option exercise | 6,656 | $0.00 |
| 2026-06-30 | Phillips Elizabeth D | SVP, People & Culture | Disposition to issuer | 4,995 | $36.25 |
| 2026-06-30 | Phillips Elizabeth D | SVP, People & Culture | Tax withholding | 793 | $36.25 |
| 2026-06-30 | Ranade Mandar | SVP, IT & Engineering | Option exercise | 7,227 | $0.00 |
| 2026-06-30 | Ranade Mandar | SVP, IT & Engineering | Disposition to issuer | 1,800 | $36.25 |
| 2026-06-30 | Ranade Mandar | SVP, IT & Engineering | Tax withholding | 1,877 | $36.25 |
| 2026-06-30 | Noble Ryan S. | SVP, Sales & Marketing Dev | Option exercise | 7,206 | $0.00 |
| 2026-06-30 | Noble Ryan S. | SVP, Sales & Marketing Dev | Disposition to issuer | 3,000 | $36.25 |
| 2026-06-30 | Noble Ryan S. | SVP, Sales & Marketing Dev | Tax withholding | 1,809 | $36.25 |
| 2026-06-30 | Batdorff Douglas J. | SVP, Manufacturing Operations | Option exercise | 7,451 | $0.00 |
| 2026-06-30 | Batdorff Douglas J. | SVP, Manufacturing Operations | Disposition to issuer | 5,609 | $36.25 |
| 2026-06-30 | Batdorff Douglas J. | SVP, Manufacturing Operations | Tax withholding | 851 | $36.25 |
| 2026-06-30 | Gardner Donald T. III | Chief Financial Officer | Option exercise | 21,265 | $0.00 |
| 2026-06-30 | Gardner Donald T. III | Chief Financial Officer | Disposition to issuer | 12,000 | $36.25 |
| 2026-06-30 | Gardner Donald T. III | Chief Financial Officer | Tax withholding | 4,027 | $36.25 |
| 2026-06-30 | HULL THOMAS DAVID III | President & CEO | Option exercise | 54,388 | $0.00 |
| 2026-06-30 | HULL THOMAS DAVID III | President & CEO | Disposition to issuer | 17,000 | $36.25 |
| 2026-06-30 | HULL THOMAS DAVID III | President & CEO | Tax withholding | 16,243 | $36.25 |
| 2026-05-01 | Campbell John Jette | Director | Grant / award | 2,013 | $0.00 |
| 2026-05-01 | GEHL KEITH M | Director | Grant / award | 2,013 | $0.00 |
| 2026-03-26 | PYLE MARGARET B | Director | Gift | 2,750 | $0.00 |
| 2026-01-07 | HULL THOMAS DAVID III | President, CEO | Open market sale | 2,177 | $37.50 |
| 2026-01-06 | Gardner Donald T. III | Chief Financial Officer | Open market sale | 2,000 | $37.57 |
| 2025-12-31 | HULL THOMAS DAVID III | President, CEO | Open market sale | 629 | $37.66 |
| 2025-12-30 | HULL THOMAS DAVID III | President, CEO | Open market sale | 29 | $38.00 |
| 2025-12-29 | HULL THOMAS DAVID III | President, CEO | Open market sale | 884 | $38.01 |
| 2025-12-22 | HULL THOMAS DAVID III | President, CEO | Open market sale | 1,000 | $39.00 |
| 2025-12-17 | HULL THOMAS DAVID III | President, CEO | Open market sale | 1,000 | $39.00 |
| 2025-10-09 | Gardner Donald T. III | Chief Financial Officer | Open market sale | 3,000 | $42.76 |
| 2025-10-02 | Phillips Elizabeth D | VP - Human Resources | Open market sale | 6,877 | $43.20 |
| 2025-10-02 | Phillips Elizabeth D | VP - Human Resources | Open market sale | 3 | $44.20 |
| 2025-10-01 | HULL THOMAS DAVID III | President, CEO | Open market sale | 1,000 | $43.09 |
| 2025-09-29 | HULL THOMAS DAVID III | President, CEO | Open market sale | 1,854 | $43.42 |
Recent SEC filings
Official company reports and insider transaction filings. Form 4 reports a transaction; it does not by itself explain why it happened.
Source: SEC EDGAR submissions · updated 2026-09-03 11:56 UTC
| Filed | Form | Report period | Official filing |
|---|---|---|---|
| 2026-08-27 | 8-K | 2026-08-26 | View on SEC.gov → |
| 2026-08-26 | 8-K | 2026-08-26 | View on SEC.gov → |
| 2026-08-25 | 8-K | 2026-08-25 | View on SEC.gov → |
| 2026-07-02 | 4 | 2026-06-30 | View on SEC.gov → |
| 2026-07-02 | 4 | 2026-06-30 | View on SEC.gov → |
| 2026-07-02 | 4 | 2026-06-30 | View on SEC.gov → |
| 2026-07-02 | 4 | 2026-06-30 | View on SEC.gov → |
| 2026-07-02 | 4 | 2026-06-30 | View on SEC.gov → |
| 2026-07-02 | 4 | 2026-06-30 | View on SEC.gov → |
| 2026-06-26 | 10-K | 2026-04-30 | View on SEC.gov → |
| 2026-06-25 | 4 | 2026-06-24 | View on SEC.gov → |
| 2026-06-25 | 4 | 2026-06-24 | View on SEC.gov → |
Recent news
Headlines about KEQU (Kewaunee Scientific Corporation). Links open the publisher — we don’t host full articles.
-
Kewaunee Scientific Posts Record $282M Revenue, Maps Fiscal 2027 Growth Investments
Yahoo Finance · 2026-08-29 -
Kewaunee Scientific Corporation (KEQU) Shareholder/Analyst Call - Slideshow
SeekingAlpha · 2026-08-26 -
Kewaunee Scientific to Report Results for First Quarter Fiscal Year 2027
Yahoo Finance · 2026-08-25 -
The Zacks Analyst Blog Highlights Eli Lilly, Costco Wholesale, Morgan Stanley and Kewaunee Scientific
Yahoo Finance · 2026-07-22 -
Top Research Reports for Eli Lilly, Costco & Morgan Stanley
Yahoo Finance · 2026-07-21 -
Kewaunee Scientific Q4 Earnings & Sales Fall Y/Y on Project Timing
Yahoo Finance · 2026-06-29 -
Kewaunee Scientific: Backlog Suggests That A Tough Year Is Ahead
Seeking Alpha · 2026-06-26 -
Kewaunee Scientific GAAP EPS of $1.13, revenue of $71.4M
Seeking Alpha · 2026-06-23
No headlines in this category right now — try “All”.